B&G Foods Reports Financial Results for First Quarter 2022
B&G Foods reported Q1 2022 net sales of $532.4 million, a 5.4% increase from Q1 2021, largely driven by pricing initiatives and elevated demand. However, diluted EPS fell to $0.34, a 17.1% drop year-over-year. Adjusted EBITDA was $77.9 million, down 16.2%, impacted by high input cost inflation and supply chain disruptions. The company raised its full-year net sales guidance to $2.10 billion - $2.14 billion, but cautioned against ongoing inflation and supply chain issues, which could affect future performance.
- Net sales increased 5.4% to $532.4 million compared to Q1 2021.
- Raised full-year net sales guidance to $2.10 billion - $2.14 billion.
- Diluted EPS decreased to $0.34, a drop of 17.1% from Q1 2021.
- Adjusted EBITDA fell 16.2% to $77.9 million due to input cost inflation.
— Net Sales Increased
Summary
|
|
|
|
|
|
|
Q1 2022 |
||||
(In millions, except per share data) |
|
|
Change vs. |
||
|
Amount |
|
Q1 2021 |
||
|
$ |
532.4 |
|
5.4 |
% |
Base Business |
$ |
532.2 |
|
5.6 |
% |
Diluted EPS 2 |
$ |
0.34 |
|
(17.1) |
% |
Adj. Diluted EPS 1 |
$ |
0.34 |
|
(34.6) |
% |
Net Income 2 |
$ |
23.7 |
|
(12.0) |
% |
Adj. Net Income 1 |
$ |
23.6 |
|
(30.8) |
% |
Adj. EBITDA 1 |
$ |
77.9 |
|
(16.2) |
% |
Guidance for Full Year Fiscal 2022
-
Net sales increased to a range of
to$2.10 billion .$2.14 billion -
Adjusted EBITDA revised to a range of
to$348 million .$358 million -
Adjusted diluted earnings per share revised to a range of
to$1.65 .$1.75
Commenting on the results,
Financial Results for the First Quarter of 2022
Net sales for the first quarter of 2022 increased
Base business net sales1 for the first quarter of 2022 increased
Net sales of Crisco increased
Gross profit was
Selling, general and administrative expenses decreased
During the first quarter of 2022, the Company completed the closure and sale of its
Net interest expense decreased
The Company’s net income was
For the first quarter of 2022, adjusted EBITDA was
For the first quarter of 2022, adjusted EBITDA before COVID-19 expenses was
Full Year Fiscal 2022 Guidance
Conference Call
About Non-GAAP Financial Measures and Items Affecting Comparability
“Adjusted net income” (net income adjusted for certain items that affect comparability), “adjusted diluted earnings per share,” (diluted earnings per share adjusted for certain items that affect comparability), “base business net sales” (net sales without the impact of acquisitions until the acquisitions are included in both comparable periods and without the impact of discontinued or divested brands), “EBITDA” (net income before net interest expense, income taxes, depreciation and amortization and loss on extinguishment of debt), “adjusted EBITDA” (EBITDA as adjusted for cash and non-cash acquisition/divestiture-related expenses, gains and losses (which may include third party fees and expenses, integration, restructuring and consolidation expenses, amortization of acquired inventory fair value step-up and gains and losses on the sale of certain assets) and non-recurring expenses, gains and losses) and “adjusted EBITDA before COVID-19 expenses” (adjusted EBITDA as adjusted for COVID-19 expenses3) are “non-GAAP financial measures.” A non-GAAP financial measure is a numerical measure of financial performance that excludes or includes amounts so as to be different than the most directly comparable measure calculated and presented in accordance with generally accepted accounting principles in
The Company uses non-GAAP financial measures to adjust for certain items that affect comparability. This information is provided in order to allow investors to make meaningful comparisons of the Company’s operating performance between periods and to view the Company’s business from the same perspective as the Company’s management. Because the Company cannot predict the timing and amount of these items that affect comparability, management does not consider these items when evaluating the Company’s performance or when making decisions regarding allocation of resources.
Additional information regarding EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses, and a reconciliation of EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses to net income and to net cash provided by operating activities, is included below for the first quarter of 2022 and 2021, along with the components of EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses. Also included below are reconciliations of the non-GAAP terms adjusted net income, adjusted diluted earnings per share and base business net sales to the most directly comparable measure calculated and presented in accordance with GAAP in the Company’s consolidated balance sheets and related consolidated statements of operations, comprehensive income, changes in stockholders’ equity and cash flows.
End Notes
- Please see “About Non-GAAP Financial Measures and Items Affecting Comparability” below for the definition of the non-GAAP financial measures “base business net sales,” “adjusted diluted earnings per share,” “adjusted net income,” “EBITDA,” “adjusted EBITDA” and “adjusted EBITDA before COVID-19 expenses,” as well as information concerning certain items affecting comparability and reconciliations of the non-GAAP terms to the most comparable GAAP financial measures.
- Includes the spices & seasoning brands acquired in the fourth quarter of 2016, as well as the Company’s legacy spices & seasonings brands, such as Dash and Ac’cent.
-
COVID-19 expenses include temporary enhanced compensation that ended on
February 15, 2021 for the Company’s manufacturing employees, compensation the Company continued to pay manufacturing employees while in quarantine (which was incremental to the compensation the Company paid to the manufacturing employees who produced the Company’s products while others were in quarantine), and expenses relating to other precautionary health and safety measures.
About
Based in
Forward-Looking Statements
Statements in this press release that are not statements of historical or current fact constitute “forward-looking statements.” The forward-looking statements contained in this press release include, without limitation, statements related to B&G Foods’ expectations regarding net sales, adjusted EBITDA, adjusted diluted earnings per share, consumer demand, input cost inflation, list price increases, cost savings initiatives, the ability of the Company to recover higher costs in the second half of 2022 through pricing actions, and the Company’s overall expectations for the remainder of fiscal 2022 and beyond. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the actual results of
|
|||||
|
|
|
|
|
|
|
|
|
|
||
|
2022 |
|
2022 |
||
Assets |
|
|
|
|
|
Current assets: |
|
|
|
|
|
Cash and cash equivalents |
$ |
41,470 |
|
$ |
33,690 |
Trade accounts receivable, net |
|
164,190 |
|
|
145,281 |
Inventories |
|
612,768 |
|
|
609,794 |
Assets held for sale |
|
— |
|
|
3,256 |
Prepaid expenses and other current assets |
|
40,307 |
|
|
38,151 |
Income tax receivable |
|
1,137 |
|
|
4,284 |
Total current assets |
|
859,872 |
|
|
834,456 |
|
|
|
|
|
|
Property, plant and equipment, net |
|
334,187 |
|
|
341,471 |
Operating lease right-of-use assets |
|
63,330 |
|
|
65,166 |
|
|
644,949 |
|
|
644,871 |
Other intangible assets, net |
|
1,922,090 |
|
|
1,927,119 |
Other assets |
|
7,081 |
|
|
6,916 |
Deferred income taxes |
|
7,842 |
|
|
8,546 |
Total assets |
$ |
3,839,351 |
|
$ |
3,828,545 |
|
|
|
|
|
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
Trade accounts payable |
$ |
152,309 |
|
$ |
129,861 |
Accrued expenses |
|
47,719 |
|
|
66,901 |
Current portion of operating lease liabilities |
|
13,502 |
|
|
12,420 |
Income tax payable |
|
2,093 |
|
|
2,557 |
Dividends payable |
|
32,721 |
|
|
32,548 |
Total current liabilities |
|
248,344 |
|
|
244,287 |
|
|
|
|
|
|
Long-term debt |
|
2,281,195 |
|
|
2,267,759 |
Deferred income taxes |
|
312,604 |
|
|
310,641 |
Long-term operating lease liabilities, net of current portion |
|
52,628 |
|
|
55,607 |
Other liabilities |
|
30,614 |
|
|
29,997 |
Total liabilities |
|
2,925,385 |
|
|
2,908,291 |
|
|
|
|
|
|
Stockholders’ equity: |
|
|
|
|
|
Preferred stock, |
|
— |
|
|
— |
Common stock, |
|
689 |
|
|
685 |
Additional paid-in capital |
|
— |
|
|
3,547 |
Accumulated other comprehensive loss |
|
(15,469) |
|
|
(18,169) |
Retained earnings |
|
928,746 |
|
|
934,191 |
Total stockholders’ equity |
|
913,966 |
|
|
920,254 |
Total liabilities and stockholders’ equity |
$ |
3,839,351 |
|
$ |
3,828,545 |
|
|||||
|
|
|
|
|
|
|
First Quarter Ended |
||||
|
|
|
|
||
|
2022 |
|
2021 |
||
Net sales |
$ |
532,407 |
|
$ |
505,134 |
Cost of goods sold |
|
431,119 |
|
|
387,340 |
Gross profit |
|
101,288 |
|
|
117,794 |
|
|
|
|
|
|
Operating (income) and expenses: |
|
|
|
|
|
Selling, general and administrative expenses |
|
46,840 |
|
|
50,379 |
Amortization expense |
|
5,223 |
|
|
5,436 |
Gain on sales of assets |
|
(7,099) |
|
|
— |
Operating income |
|
56,324 |
|
|
61,979 |
|
|
|
|
|
|
Other income and expenses: |
|
|
|
|
|
Interest expense, net |
|
26,802 |
|
|
26,969 |
Other income |
|
(1,839) |
|
|
(1,091) |
Income before income tax expense |
|
31,361 |
|
|
36,101 |
Income tax expense |
|
7,705 |
|
|
9,223 |
Net income |
$ |
23,656 |
|
$ |
26,878 |
|
|
|
|
|
|
Weighted average shares outstanding: |
|
|
|
|
|
Basic |
|
68,630 |
|
|
64,583 |
Diluted |
|
69,017 |
|
|
65,210 |
|
|
|
|
|
|
Earnings per share: |
|
|
|
|
|
Basic |
$ |
0.34 |
|
$ |
0.42 |
Diluted |
$ |
0.34 |
|
$ |
0.41 |
|
|
|
|
|
|
Cash dividends declared per share |
$ |
0.475 |
|
$ |
0.475 |
|
||||||
|
|
|
|
|
|
|
|
|
First Quarter Ended |
||||
|
|
|
|
|
||
|
|
2022 |
|
2021 |
||
Net income |
|
$ |
23,656 |
|
$ |
26,878 |
Income tax expense |
|
|
7,705 |
|
|
9,223 |
Interest expense, net |
|
|
26,802 |
|
|
26,969 |
Depreciation and amortization |
|
|
19,825 |
|
|
20,291 |
EBITDA(1) |
|
|
77,988 |
|
|
83,361 |
Acquisition/divestiture-related and non-recurring (income) expenses(2) |
|
|
(87) |
|
|
4,510 |
Amortization of acquisition-related inventory step-up(3) |
|
|
— |
|
|
5,054 |
Adjusted EBITDA(1) |
|
|
77,901 |
|
|
92,925 |
COVID-19 expenses(4) |
|
|
500 |
|
|
2,891 |
Adjusted EBITDA before COVID-19 expenses(1) |
|
|
78,401 |
|
|
95,816 |
Income tax expense |
|
|
(7,705) |
|
|
(9,223) |
Interest expense, net |
|
|
(26,802) |
|
|
(26,969) |
Acquisition/divestiture-related and non-recurring income (expenses)(2) |
|
|
87 |
|
|
(4,510) |
Amortization of acquisition-related inventory step-up(3) |
|
|
— |
|
|
(5,054) |
Gain on sales of assets |
|
|
(7,113) |
|
|
(26) |
Deferred income taxes |
|
|
2,913 |
|
|
6,188 |
Amortization of deferred debt financing costs and bond discount/premium |
|
|
1,169 |
|
|
1,141 |
Share-based compensation expense |
|
|
1,090 |
|
|
723 |
Changes in assets and liabilities, net of effects of business combinations |
|
|
(16,309) |
|
|
(29,175) |
Net cash provided by operating activities |
|
$ |
25,231 |
|
$ |
26,020 |
(1) | EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses are non-GAAP financial measures used by management to measure operating performance. A non-GAAP financial measure is defined as a numerical measure of the Company’s financial performance that excludes or includes amounts so as to be different from the most directly comparable measure calculated and presented in accordance with GAAP in the Company’s consolidated balance sheets and related consolidated statements of operations, comprehensive income, changes in stockholders’ equity and cash flows. The Company defines EBITDA as net income before net interest expense, income taxes, depreciation and amortization and loss on extinguishment of debt. The Company defines adjusted EBITDA as EBITDA adjusted for cash and non-cash acquisition/divestiture-related expenses, gains and losses (which may include third party fees and expenses, integration, restructuring and consolidation expenses, amortization of acquired inventory fair value step-up, and gains and losses on the sale of certain assets); and non-recurring expenses, gains and losses. The Company defines adjusted EBITDA before COVID-19 expenses as adjusted EBITDA adjusted for COVID-19 expenses. |
|
Management believes that it is useful to eliminate these items because it allows management to focus on what it deems to be a more reliable indicator of ongoing operating performance and the Company’s ability to generate cash flow from operations. The Company uses EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses in the Company’s business operations to, among other things, evaluate the Company’s operating performance, develop budgets and measure the Company’s performance against those budgets, determine employee bonuses and evaluate the Company’s cash flows in terms of cash needs. The Company also presents EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses because the Company believes they are useful indicators of the Company’s historical debt capacity and ability to service debt and because covenants in the Company’s credit agreement and the Company’s senior notes indentures contain ratios based on these measures. As a result, reports used by internal management during monthly operating reviews feature the EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses metrics. However, management uses these metrics in conjunction with traditional GAAP operating performance and liquidity measures as part of its overall assessment of company performance and liquidity, and therefore does not place undue reliance on these measures as its only measures of operating performance and liquidity. |
||
EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses are not recognized terms under GAAP and do not purport to be alternatives to operating income, net income or any other GAAP measure as an indicator of operating performance. EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses are not complete net cash flow measures because EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses are measures of liquidity that do not include reductions for cash payments for an entity’s obligation to service its debt, fund its working capital, capital expenditures and acquisitions and pay its income taxes and dividends. Rather, EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses are potential indicators of an entity’s ability to fund these cash requirements. EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses are not complete measures of an entity’s profitability because they do not include certain costs and expenses and gains and losses described above. Because not all companies use identical calculations, this presentation of EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses may not be comparable to other similarly titled measures of other companies. However, EBITDA, adjusted EBITDA and adjusted EBITDA before COVID-19 expenses can still be useful in evaluating the Company’s performance against the Company’s peer companies because management believes these measures provide users with valuable insight into key components of GAAP amounts. |
||
(2) |
Acquisition/divestiture-related and non-recurring expenses for the first quarter of 2021 of |
|
(3) |
For the first quarter of 2021, amortization of acquisition-related inventory step-up of |
|
(4) |
COVID-19 expenses of |
|
|
|||||
|
|
|
|
|
|
|
First Quarter Ended |
||||
|
|
|
|
||
|
2022 |
|
2021 |
||
Net income |
$ |
23,656 |
|
$ |
26,878 |
Acquisition/divestiture-related and non-recurring (income) expenses, net of tax(1) |
|
(66) |
|
|
3,405 |
Amortization of acquisition-related inventory step-up, net of tax(2) |
|
— |
|
|
3,816 |
Adjusted net income |
$ |
23,590 |
|
$ |
34,099 |
Adjusted diluted earnings per share |
$ |
0.34 |
|
$ |
0.52 |
(1) | Acquisition/divestiture-related and non-recurring expenses for the first quarter of 2021 primarily includes acquisition and integration expenses for the Crisco and Clabber Girl acquisitions, and certain cost savings initiatives. |
|
(2) |
For the first quarter of 2021, amortization of acquisition-related inventory step-up of |
|
|
|||||
|
|
|
|
|
|
|
First Quarter Ended |
||||
|
|
|
|
||
|
2022 |
|
2021 |
||
Net sales |
$ |
532,407 |
|
$ |
505,134 |
Net sales from discontinued brands(2) |
|
(239) |
|
|
(1,002) |
Base business net sales |
$ |
532,168 |
|
$ |
504,132 |
(1) | Base business net sales is a non-GAAP financial measure used by management to measure operating performance. The Company defines base business net sales as the Company’s net sales excluding (1) the net sales of acquisitions until the net sales from such acquisitions are included in both comparable periods and (2) net sales of discontinued or divested brands. The portion of current period net sales attributable to recent acquisitions for which there is no corresponding period in the comparable period of the prior year is excluded. For each acquisition, the excluded period starts at the beginning of the most recent fiscal period being compared and ends on the first anniversary of the acquisition date. For discontinued or divested brands, the entire amount of net sales is excluded from each fiscal period being compared. The Company has included this financial measure because management believes it provides useful and comparable trend information regarding the results of the Company’s business without the effect of the timing of acquisitions and the effect of discontinued or divested brands. |
|
(2) | Reflects net sales of the SnackWell’s and Farmwise brands, which are being discontinued. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220505006046/en/
Investor Relations:
866.211.8151
Media Relations:
203.682.8214
Source:
FAQ
What were BGS's net sales for Q1 2022?
How did BGS's EPS change in Q1 2022?
What is BGS's guidance for full-year 2022?
What factors impacted BGS's Q1 2022 performance?